Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Buy
71
MODG Quote, Financials, Valuation and Earnings
Last price:
$14.68
Seasonality move
:
6.65%
Day range:
$14.45 - $15.02
52-week range:
$5.42 - $15.02
Dividend yield:
0%
P/E ratio:
100.60x
P/S ratio:
0.67x
P/B ratio:
1.09x
Volume:
3.9M
Avg. volume:
2.6M
1-year change:
80.57%
Market cap:
$2.7B
Revenue:
$4.2B
EPS (TTM):
-$8.19
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.6B | $3.1B | $4B | $4.3B | $4.2B | |
| Revenue Growth (YoY) | -6.56% | 97.14% | 27.52% | 7.24% | -1.06% | |
| Cost of Revenues | $932.9M | $1.3B | $1.6B | $1.6B | $1.6B | |
| Gross Profit | $656.6M | $1.8B | $2.4B | $2.6B | $2.6B | |
| Gross Profit Margin | 41.31% | 59% | 60.08% | 61.75% | 62.4% | |
| R&D Expenses | $46.3M | $68M | $76.4M | $101.6M | $92.1M | |
| Selling, General & Admin | $542.5M | $1.6B | $2B | $2.3B | $2.3B | |
| Other Inc / (Exp) | -$149.4M | $252.1M | -$2.5M | -$18.6M | -$1.5B | |
| Operating Expenses | $588.8M | $1.6B | $2.1B | $2.4B | $2.4B | |
| Operating Income | $67.7M | $212.4M | $292M | $269.5M | $215.5M | |
| Net Interest Expenses | $49.5M | $121M | $144.8M | $218.8M | $241.5M | |
| EBT. Incl. Unusual Items | -$127.5M | $350.6M | $141.9M | $34.8M | -$1.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$544K | $28.7M | -$16M | -$60.2M | -$25.5M | |
| Net Income to Company | -$126.9M | $322M | $157.9M | $95M | -$1.4B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$126.9M | $322M | $157.9M | $95M | -$1.4B | |
| Basic EPS (Cont. Ops) | -$1.35 | $1.90 | $0.85 | $0.51 | -$7.88 | |
| Diluted EPS (Cont. Ops) | -$1.35 | $1.82 | $0.78 | $0.47 | -$7.88 | |
| Weighted Average Basic Share | $94.2M | $169.1M | $184.9M | $185M | $183.7M | |
| Weighted Average Diluted Share | $94.2M | $176.9M | $201.3M | $201.1M | $183.7M | |
| EBITDA | $140M | $448.2M | $484.8M | $509.2M | $483.9M | |
| EBIT | $67.7M | $212.4M | $292M | $269.5M | $215.5M | |
| Revenue (Reported) | $1.6B | $3.1B | $4B | $4.3B | $4.2B | |
| Operating Income (Reported) | $67.7M | $212.4M | $292M | $269.5M | $215.5M | |
| Operating Income (Adjusted) | $67.7M | $212.4M | $292M | $269.5M | $215.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $856.5M | $988.5M | $1B | $1B | $934M | |
| Revenue Growth (YoY) | 80.1% | 15.42% | 5.27% | -2.66% | -7.79% | |
| Cost of Revenues | $331.8M | $384.3M | $390.1M | $378.1M | $329M | |
| Gross Profit | $524.7M | $604.2M | $650.5M | $634.8M | $605M | |
| Gross Profit Margin | 61.26% | 61.12% | 62.51% | 62.67% | 64.78% | |
| R&D Expenses | $15.8M | $19.2M | $22.6M | $22M | $20.1M | |
| Selling, General & Admin | $217.7M | $512.3M | $554.6M | $576.2M | $553.5M | |
| Other Inc / (Exp) | $200K | -$2.9M | -$1.7M | -$2.9M | -- | |
| Operating Expenses | $426.9M | $527.2M | $574.4M | $595.3M | $566.7M | |
| Operating Income | $97.8M | $77M | $76.1M | $39.5M | $38.3M | |
| Net Interest Expenses | $27.6M | $35.1M | $54.2M | $60.4M | $60.2M | |
| EBT. Incl. Unusual Items | $50.2M | $38.8M | $26.7M | -$23M | -$22.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $66.2M | $300K | -$3M | -$19.4M | -$7.6M | |
| Net Income to Company | -$16M | $38.5M | $29.7M | -$3.6M | -$14.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$16M | $38.5M | $29.7M | -$3.6M | -$14.7M | |
| Basic EPS (Cont. Ops) | -$0.09 | $0.21 | $0.16 | -$0.02 | -$0.08 | |
| Diluted EPS (Cont. Ops) | -$0.09 | $0.19 | $0.16 | -$0.02 | -$0.08 | |
| Weighted Average Basic Share | $186M | $184.8M | $185.2M | $183.8M | $183.9M | |
| Weighted Average Diluted Share | $186M | $201.8M | $201.2M | $183.8M | $183.9M | |
| EBITDA | $161.2M | $150.8M | $137.1M | $107.6M | $103.8M | |
| EBIT | $97.8M | $77M | $76.1M | $39.5M | $38.3M | |
| Revenue (Reported) | $856.5M | $988.5M | $1B | $1B | $934M | |
| Operating Income (Reported) | $97.8M | $77M | $76.1M | $39.5M | $38.3M | |
| Operating Income (Adjusted) | $97.8M | $77M | $76.1M | $39.5M | $38.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.8B | $3.9B | $4.2B | $4.2B | $4.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.3B | $1.6B | $1.6B | $1.6B | $1.5B | |
| Gross Profit | $1.5B | $2.3B | $2.6B | $2.6B | $2.6B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $61.7M | $74.6M | $88.4M | $106.4M | $81.1M | |
| Selling, General & Admin | $771.2M | $2B | $2.3B | $2.3B | $2.3B | |
| Other Inc / (Exp) | $249.9M | $8.3M | -$25.2M | -$3.8M | -- | |
| Operating Expenses | $1.3B | $2.1B | $2.3B | $2.4B | $2.4B | |
| Operating Income | $271.9M | $235.1M | $259.8M | $211.8M | $208.8M | |
| Net Interest Expenses | $86M | $143M | $200.4M | $242.6M | $238.9M | |
| EBT. Incl. Unusual Items | $398.6M | $122.4M | $42.9M | -$43.4M | -$1.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $91M | -$82M | -$56.5M | -$31.3M | $14.3M | |
| Net Income to Company | $307.6M | $204.4M | $99.4M | -$12.1M | -$1.5B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $307.6M | $204.4M | $99.4M | -$12.1M | -$1.5B | |
| Basic EPS (Cont. Ops) | $2.30 | $1.11 | $0.54 | -$0.06 | -$8.19 | |
| Diluted EPS (Cont. Ops) | $2.14 | $1.01 | $0.47 | -$0.08 | -$8.19 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $444.9M | $530.2M | $545.2M | $475.1M | $480.3M | |
| EBIT | $271.9M | $235.1M | $259.8M | $211.8M | $208.8M | |
| Revenue (Reported) | $2.8B | $3.9B | $4.2B | $4.2B | $4.1B | |
| Operating Income (Reported) | $271.9M | $235.1M | $259.8M | $211.8M | $208.8M | |
| Operating Income (Adjusted) | $271.9M | $235.1M | $259.8M | $211.8M | $208.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.4B | $3.1B | $3.4B | $3.3B | $3.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1B | $1.3B | $1.3B | $1.3B | $1.2B | |
| Gross Profit | $1.4B | $1.9B | $2.1B | $2.1B | $2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $48.8M | $55.4M | $67.4M | $72.2M | $61.2M | |
| Selling, General & Admin | $612.7M | $1.5B | $1.7B | $1.8B | $1.7B | |
| Other Inc / (Exp) | $252.5M | $8.8M | -$13.9M | $900K | -$12.3M | |
| Operating Expenses | $1.1B | $1.5B | $1.8B | $1.8B | $1.8B | |
| Operating Income | $303.6M | $307M | $276.8M | $219.1M | $212.4M | |
| Net Interest Expenses | $71.8M | $101M | $153.1M | $181.7M | $179.1M | |
| EBT. Incl. Unusual Items | $446.3M | $218.1M | $119.1M | $40.9M | $23.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $98.1M | -$12.5M | -$53M | -$24.1M | $15.7M | |
| Net Income to Company | $348.2M | $230.6M | $172.1M | $65M | $7.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $348.2M | $230.6M | $172.1M | $65M | $7.7M | |
| Basic EPS (Cont. Ops) | $2.73 | $1.25 | $0.93 | $0.35 | $0.04 | |
| Diluted EPS (Cont. Ops) | $2.57 | $1.15 | $0.86 | $0.34 | $0.04 | |
| Weighted Average Basic Share | $488.7M | $554.6M | $555.6M | $551M | $551.1M | |
| Weighted Average Diluted Share | $504.9M | $603.2M | $604M | $567.8M | $552.5M | |
| EBITDA | $457.5M | $514.4M | $509.2M | $418.4M | $414.8M | |
| EBIT | $303.6M | $307M | $276.8M | $219.1M | $212.4M | |
| Revenue (Reported) | $2.4B | $3.1B | $3.4B | $3.3B | $3.1B | |
| Operating Income (Reported) | $303.6M | $307M | $276.8M | $219.1M | $212.4M | |
| Operating Income (Adjusted) | $303.6M | $307M | $276.8M | $219.1M | $212.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $366.1M | $353.4M | $199.3M | $394.3M | $445.7M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $138.5M | $105.3M | $167.3M | $200.5M | $175.7M | |
| Inventory | $352.5M | $533.5M | $959.2M | $794.4M | $757.3M | |
| Prepaid Expenses | -- | $54.2M | $57.1M | $55.8M | $61.7M | |
| Other Current Assets | $32M | $68.6M | $56.6M | $47.2M | $53.4M | |
| Total Current Assets | $911.6M | $1.2B | $1.5B | $1.6B | $1.6B | |
| Property Plant And Equipment | $341.3M | $3B | $3.4B | $3.8B | $3.8B | |
| Long-Term Investments | $111.4M | $87.6M | $103.7M | $80.9M | $123.8M | |
| Goodwill | $56.7M | $2B | $2B | $2B | $620.2M | |
| Other Intangibles | $484.3M | $1.5B | $1.5B | $1.5B | $1.4B | |
| Other Long-Term Assets | $74.3M | $257.5M | $355.4M | $431.7M | $484.4M | |
| Total Assets | $2B | $7.7B | $8.6B | $9.1B | $7.6B | |
| Accounts Payable | $66.3M | $138.7M | $159.1M | $130.7M | $96.4M | |
| Accrued Expenses | $240.9M | $352.5M | $420.9M | $349.8M | $354.9M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $29.6M | $72.3M | $76.4M | $86.4M | $89.3M | |
| Other Current Liabilities | $29.9M | $47.7M | $35M | $42.7M | $44.5M | |
| Total Current Liabilities | $391.3M | $866M | $1.2B | $947.6M | $825.9M | |
| Long-Term Debt | $829M | $3B | $3.5B | $4.2B | $4.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.3B | $4.1B | $4.8B | $5.2B | $5.2B | |
| Common Stock | $956K | $1.9M | $1.9M | $1.9M | $1.9M | |
| Other Common Equity Adj | -$6.5M | -$27.3M | -$61.5M | -$47.5M | -$76M | |
| Common Equity | $675.6M | $3.7B | $3.8B | $3.9B | $2.4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $675.6M | $3.7B | $3.8B | $3.9B | $2.4B | |
| Total Liabilities and Equity | $2B | $7.7B | $8.6B | $9.1B | $7.6B | |
| Cash and Short Terms | $366.1M | $353.4M | $199.3M | $394.3M | $445.7M | |
| Total Debt | $843.9M | $3B | $3.5B | $4.2B | $4.3B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $509.9M | $200.8M | $331M | $442.6M | $865.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $267.2M | $275M | $304.6M | $286.4M | $218.5M | |
| Inventory | $385.3M | $722.3M | $736.5M | $666.4M | $568.7M | |
| Prepaid Expenses | $48.2M | $47.4M | $59.5M | $65.6M | $70.9M | |
| Other Current Assets | $140.8M | $93.5M | $90.4M | $59.4M | -- | |
| Total Current Assets | $1.3B | $1.4B | $1.6B | $1.6B | $1.9B | |
| Property Plant And Equipment | $2.4B | $3.3B | $3.7B | $3.8B | $3.7B | |
| Long-Term Investments | $47.9M | $96.5M | $118.2M | $117.8M | $127.1M | |
| Goodwill | $2B | $2B | $2B | $2B | -- | |
| Other Intangibles | $1.5B | $1.5B | $1.5B | $1.5B | -- | |
| Other Long-Term Assets | $90M | $304.8M | $404.9M | $199.6M | -- | |
| Total Assets | $7.4B | $8.2B | $9B | $9.2B | $7.6B | |
| Accounts Payable | $126.6M | $155.4M | $103.1M | $123.1M | $87.1M | |
| Accrued Expenses | $442.9M | $370.6M | $283M | $330.3M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $15.6M | -- | |
| Current Portion Of Capital Lease Obligations | $55.5M | $72.7M | $82.8M | $88.9M | -- | |
| Other Current Liabilities | $46.3M | $45.3M | $35.6M | $19.2M | -- | |
| Total Current Liabilities | $840.2M | $1B | $909.2M | $842.5M | $998.7M | |
| Long-Term Debt | $2.6B | $3.2B | $4B | $4.3B | $4.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.7B | $4.4B | $5B | $5.2B | $5.1B | |
| Common Stock | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | |
| Other Common Equity Adj | -$25.4M | -$92.6M | -$54.3M | -$51.7M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $3.7B | $3.8B | $4B | $3.9B | $2.5B | |
| Total Liabilities and Equity | $7.4B | $8.2B | $9B | $9.2B | $7.6B | |
| Cash and Short Terms | $509.9M | $200.8M | $331M | $442.6M | $865.6M | |
| Total Debt | $2.6B | $3.2B | $4B | $4.3B | $4.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$126.9M | $322M | $157.9M | $95M | -$1.4B | |
| Depreciation & Amoritzation | $72.2M | $235.8M | $287M | $239.7M | $268.4M | |
| Stock-Based Compensation | $10.9M | $38.7M | $47M | $46.7M | $37M | |
| Change in Accounts Receivable | $10M | $38.2M | -$97.8M | -$43.7M | $6.6M | |
| Change in Inventories | $117M | -$177.5M | -$442.4M | $163.2M | $12.2M | |
| Cash From Operations | $228.2M | $278.3M | -$35.1M | $364.7M | $382M | |
| Capital Expenditures | $39.3M | $322.3M | $535.5M | $482.8M | $298.6M | |
| Cash Acquisitions | -- | -- | -- | $60.9M | $23.3M | |
| Cash From Investing | -$59.2M | -$161.9M | -$535.1M | -$542.9M | -$297.3M | |
| Dividends Paid (Ex Special Dividend) | $1.9M | $3K | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $296.5M | $115.4M | $352.5M | $1.5B | $115.5M | |
| Long-Term Debt Repaid | -$13.2M | -$201.5M | -$99.3M | -$797.3M | -$82.1M | |
| Repurchase of Common Stock | $22.2M | $38.1M | $35.8M | $56M | $31.4M | |
| Other Financing Activities | -$40.8M | -$9M | -$5.8M | -$1.8M | -$200K | |
| Cash From Financing | $96.1M | -$124.1M | $425.3M | $375.8M | -$23.6M | |
| Beginning Cash (CF) | $366.1M | $353.4M | $199.3M | $394.3M | $445.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $259.5M | -$8.4M | -$154.3M | $195.4M | $51.5M | |
| Ending Cash (CF) | $619.9M | $344.2M | $35.6M | $587.5M | $487.6M | |
| Levered Free Cash Flow | $189M | -$44M | -$570.6M | -$118.1M | $83.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$16M | $38.5M | $29.7M | -$3.6M | -$14.7M | |
| Depreciation & Amoritzation | $63.5M | $73.8M | $12.7M | $68.1M | $65.5M | |
| Stock-Based Compensation | $11.5M | $10.4M | $13.6M | $7.8M | $3.9M | |
| Change in Accounts Receivable | $65.7M | $88.3M | $85M | $111.4M | $119.2M | |
| Change in Inventories | -$53.8M | -$140.1M | $93.8M | -$3.8M | $35.9M | |
| Cash From Operations | $146.3M | $82.7M | $249.5M | $187.3M | $228.4M | |
| Capital Expenditures | $78.1M | $111M | $126.2M | $79.6M | $66.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$59.5M | -$110.6M | -$139.2M | -$80.6M | -$66.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $52.7M | $44.2M | $73M | $33M | -- | |
| Long-Term Debt Repaid | -$38.4M | -$4.8M | -$22.3M | -$15.1M | -- | |
| Repurchase of Common Stock | $400K | $1M | $16.7M | $100K | $100K | |
| Other Financing Activities | -- | -- | -$500K | -- | -- | |
| Cash From Financing | $15.1M | $43.5M | $33.7M | $17.9M | $21.6M | |
| Beginning Cash (CF) | $509.9M | $200.8M | $331M | $442.6M | $865.6M | |
| Foreign Exchange Rate Adjustment | -$5.7M | $6.1M | -$5.2M | $5.8M | -$1M | |
| Additions / Reductions | $96.2M | $21.7M | $138.8M | $130.4M | $182.1M | |
| Ending Cash (CF) | $600.4M | $228.6M | $464.6M | $578.8M | $1B | |
| Levered Free Cash Flow | $68.3M | -$28.3M | $123.3M | $107.7M | $162M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $307.6M | $204.4M | $99.4M | -$12.1M | -$1.5B | |
| Depreciation & Amoritzation | $173.2M | $289.3M | $255.3M | $263.3M | $271.5M | |
| Stock-Based Compensation | $30M | $49M | $48M | $36.2M | $27M | |
| Change in Accounts Receivable | -$21.1M | -$43.1M | -$43M | $17.8M | $52.7M | |
| Change in Inventories | -$46.3M | -$386.1M | -$700K | $82.7M | $5.8M | |
| Cash From Operations | $352.5M | $66.1M | $158M | $475.7M | $313.4M | |
| Capital Expenditures | $207.2M | $477.4M | $571M | $323.5M | $279.9M | |
| Cash Acquisitions | -- | -- | -- | $60.9M | $23.3M | |
| Cash From Investing | -$17.3M | -$506.5M | -$601.4M | -$377.6M | $30.7M | |
| Dividends Paid (Ex Special Dividend) | $3K | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $77.5M | $231M | $1.6B | $177.6M | -- | |
| Long-Term Debt Repaid | -$165.9M | -$127.4M | -$1B | $148M | -- | |
| Repurchase of Common Stock | $13M | $60.7M | $44.3M | $43.4M | $3.4M | |
| Other Financing Activities | -$8.9M | -$5.6M | -$2M | -$200K | -- | |
| Cash From Financing | -$98.8M | $127.5M | $591.4M | $10M | $76.2M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $227.2M | -$309.3M | $130.7M | $112.2M | $418.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $145.2M | -$411.3M | -$413M | $152.2M | $33.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $348.2M | $230.6M | $172.1M | $65M | $7.7M | |
| Depreciation & Amoritzation | $153.9M | $207.4M | $175.7M | $199.3M | $202.4M | |
| Stock-Based Compensation | $27.1M | $37.4M | $38.4M | $27.9M | $17.9M | |
| Change in Accounts Receivable | -$127.4M | -$208.7M | -$153.9M | -$92.4M | -$46.3M | |
| Change in Inventories | -$27.3M | -$235.9M | $205.8M | $125.3M | $118.9M | |
| Cash From Operations | $246.8M | $34.6M | $227.7M | $338.7M | $270.1M | |
| Capital Expenditures | $198.9M | $354M | $389.5M | $230.2M | $211.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$9M | -$353.6M | -$419.9M | -$254.6M | $73.4M | |
| Dividends Paid (Ex Special Dividend) | $3K | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $77.5M | $193.1M | $1.4B | $87.6M | $66.5M | |
| Long-Term Debt Repaid | -$161.4M | -$87.3M | -$1B | -$90.5M | -$19M | |
| Repurchase of Common Stock | $12.9M | $35.5M | $44M | $31.4M | $3.4M | |
| Other Financing Activities | -$9M | -$5.6M | -$1.8M | -$200K | -$400K | |
| Cash From Financing | -$86.3M | $165.3M | $331.4M | -$34.4M | $65.4M | |
| Beginning Cash (CF) | $1.3B | $625.7M | $704.4M | $989.7M | $1.9B | |
| Foreign Exchange Rate Adjustment | -$3.8M | $600K | -$7.3M | -$1M | $6.7M | |
| Additions / Reductions | $147.7M | -$153.1M | $131.9M | $48.7M | $415.6M | |
| Ending Cash (CF) | $1.5B | $473.2M | $829M | $1B | $2.3B | |
| Levered Free Cash Flow | $47.9M | -$319.4M | -$161.8M | $108.5M | $58.6M | |
Get MODG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MODG
Sector
P/E ratio
100.60x
17.56x
PEG ratio
0.00x
0.11x
P/B ratio
1.09x
1.34x
Price / LTM sales
0.67x
0.59x
Growth Metrics
MODG
Sector
Revenue growth
-7.79%
3.35%
Earnings growth
-307.65%
--
Revenue (5-year growth)
20.04%
3.16%
Earnings forecast
-$0.44
$0.25
Profitability
MODG
Sector
Profitability FY 2024
$2.6B
$293.9M
Return on invested capital
-20.95%
3.41%
Return on assets
-18.97%
2.25%
Return on equity
-54.79%
5.88%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
23
Estimated Next Earnings Date
Feb
5
Balance Sheet
MODG
Sector
Total cash
$865.6M
$128.4M
Short term investments
--
$40.6M
Total assets
$7.6B
$1.1B
Long term debt
$4.1B
$33.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 64x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
80
BNR alert for Jan 16
Burning Rock Biotech Ltd. [BNR] is down 2.85% over the past day.
Buy
90
PEN alert for Jan 16
Penumbra, Inc. [PEN] is up 0.36% over the past day.
Buy
100
TLN alert for Jan 16
Talen Energy Corp. [TLN] is down 8.86% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
